Challenges and Initiatives in Diversity, Equity and Inclusion in Cancer Molecular Imaging
A diverse biomedical workforce is essential to achieve excellence in patient care, clinical translational, and basic research. Diversity, equity, and inclusion challenges in cancer molecular represent a combination of the challenges facing the science, technology, engineering, and mathematics (STEM)...
Saved in:
Published in | Frontiers in oncology Vol. 11; p. 638692 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
09.04.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 2234-943X 2234-943X |
DOI | 10.3389/fonc.2021.638692 |
Cover
Summary: | A diverse biomedical workforce is essential to achieve excellence in patient care, clinical translational, and basic research. Diversity, equity, and inclusion challenges in cancer molecular represent a combination of the challenges facing the science, technology, engineering, and mathematics (STEM) field, and challenges in Radiology and Nuclear Medicine. Although there is a growing awareness of conscious and unconscious bias that negatively affect the cancer imaging world, many challenges remain such as overcoming barriers to entry into the pipeline, avoiding program dropout, and providing long-term career prospect. The COVID-19 pandemic has resulted in a significant setback and further highlighted problems faced by women and underrepresented minorities. In this perspective, we have identified some of the challenges faced and highlighted ongoing and future initiatives to address these challenges. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Cancer Imaging and Image-directed Interventions, a section of the journal Frontiers in Oncology Edited by: Tone Frost Bathen, Norwegian University of Science and Technology, Norway Reviewed by: Jannie Wijnen, University Medical Center Utrecht, Netherlands; Egidio Iorio, National Institute of Health (ISS), Italy |
ISSN: | 2234-943X 2234-943X |
DOI: | 10.3389/fonc.2021.638692 |